Pavestone Capital

Pavestone Capital is a Hyderabad-based venture capital firm that focuses on investing in early-stage B2B technology companies across India. The firm primarily targets sectors such as technology, healthcare, deeptech, and enterprise technology, aiming to support startups that address significant challenges in these industries.

Established in 2021 by Sridhar Rampalli, Srikanth Tanikella, and Laxmikanth V, Pavestone Capital has quickly positioned itself as a key player in the venture capital space. The firm's investment strategy emphasizes sectors like generative artificial intelligence, cloud computing, immersive technology, and bioengineering, with about 80% of funds dedicated to solving large-scale B2B challenges.

In November 2024, Pavestone Capital successfully closed its inaugural fund, the Pavestone Technology Fund, with a total corpus of INR 816 crore (approximately $97 million), surpassing its initial target of INR 600 crore. The fund attracted notable investors, including The Self-Reliant India (SRI) Fund, the family office of Mankind Pharma promoters, and Colruyt Group India. The firm plans to invest in 14-15 growth-stage B2B technology companies, with each investment ranging from $5 to $10 million, focusing on startups with substantial market traction and established relationships with significant private and public enterprise clients.